 Gregary Bocsi
Concepts (61)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Mismatch Repair | 2 | 2024 | 52 | 0.870 |
Why?
| | Microsatellite Instability | 1 | 2024 | 54 | 0.830 |
Why?
| | Endometrial Neoplasms | 1 | 2024 | 208 | 0.700 |
Why?
| | Pathology | 1 | 2020 | 21 | 0.630 |
Why?
| | Reimbursement, Incentive | 1 | 2020 | 42 | 0.620 |
Why?
| | Colorectal Neoplasms | 2 | 2024 | 848 | 0.570 |
Why?
| | Electrophoresis | 1 | 2017 | 31 | 0.520 |
Why?
| | Immunoglobulin kappa-Chains | 1 | 2017 | 23 | 0.520 |
Why?
| | Quality of Health Care | 1 | 2020 | 693 | 0.440 |
Why?
| | Medicare | 1 | 2020 | 887 | 0.420 |
Why?
| | Immunoglobulin G | 2 | 2024 | 893 | 0.410 |
Why?
| | Multiple Myeloma | 1 | 2017 | 304 | 0.400 |
Why?
| | Antibodies, Monoclonal | 1 | 2017 | 1524 | 0.300 |
Why?
| | Pathology, Clinical | 2 | 2024 | 29 | 0.250 |
Why?
| | Amyloidosis | 1 | 2025 | 44 | 0.230 |
Why?
| | Antineoplastic Agents | 1 | 2017 | 2197 | 0.230 |
Why?
| | Intestinal Neoplasms | 1 | 2024 | 30 | 0.210 |
Why?
| | Intestine, Small | 1 | 2024 | 166 | 0.190 |
Why?
| | Paraproteinemias | 1 | 2022 | 5 | 0.180 |
Why?
| | Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2021 | 40 | 0.170 |
Why?
| | Esophageal Neoplasms | 1 | 2024 | 349 | 0.160 |
Why?
| | Vaccines | 1 | 2024 | 389 | 0.140 |
Why?
| | Chemistry, Clinical | 1 | 2018 | 5 | 0.140 |
Why?
| | Immunochemistry | 1 | 2018 | 12 | 0.140 |
Why?
| | Clinical Laboratory Services | 1 | 2018 | 5 | 0.140 |
Why?
| | DNA, Neoplasm | 1 | 2019 | 164 | 0.140 |
Why?
| | Proto-Oncogene Proteins c-met | 1 | 2019 | 76 | 0.140 |
Why?
| | Quality Control | 1 | 2018 | 163 | 0.140 |
Why?
| | Biomarkers, Tumor | 1 | 2024 | 1322 | 0.130 |
Why?
| | Reproducibility of Results | 1 | 2024 | 3415 | 0.120 |
Why?
| | Thoracic Neoplasms | 1 | 2016 | 39 | 0.120 |
Why?
| | Academic Medical Centers | 1 | 2018 | 548 | 0.110 |
Why?
| | Adenocarcinoma | 1 | 2021 | 931 | 0.100 |
Why?
| | Medical Oncology | 1 | 2016 | 332 | 0.100 |
Why?
| | RNA | 1 | 2019 | 940 | 0.090 |
Why?
| | Humans | 11 | 2025 | 144957 | 0.080 |
Why?
| | Laboratories | 2 | 2022 | 109 | 0.080 |
Why?
| | United States | 3 | 2021 | 15988 | 0.070 |
Why?
| | Lung Neoplasms | 1 | 2019 | 2642 | 0.060 |
Why?
| | Female | 3 | 2024 | 78376 | 0.050 |
Why?
| | ABO Blood-Group System | 1 | 2022 | 57 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2025 | 732 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2024 | 672 | 0.040 |
Why?
| | Quality Assurance, Health Care | 1 | 2021 | 340 | 0.040 |
Why?
| | Gastroenterology | 1 | 2021 | 189 | 0.040 |
Why?
| | Quality Indicators, Health Care | 1 | 2021 | 335 | 0.040 |
Why?
| | Exons | 1 | 2019 | 358 | 0.030 |
Why?
| | Health Personnel | 1 | 2024 | 748 | 0.030 |
Why?
| | Decision Trees | 1 | 2016 | 81 | 0.030 |
Why?
| | Quality-Adjusted Life Years | 1 | 2016 | 121 | 0.030 |
Why?
| | Markov Chains | 1 | 2016 | 129 | 0.030 |
Why?
| | Incidence | 1 | 2022 | 2883 | 0.030 |
Why?
| | Adult | 1 | 2017 | 40506 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2021 | 1563 | 0.020 |
Why?
| | Periodicals as Topic | 1 | 2016 | 203 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2016 | 636 | 0.020 |
Why?
| | Research Design | 1 | 2016 | 1137 | 0.020 |
Why?
| | Mutation | 1 | 2019 | 4099 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2018 | 6053 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2022 | 17101 | 0.010 |
Why?
| | Male | 1 | 2019 | 72406 | 0.010 |
Why?
|
|
Bocsi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|